High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
Phull, Pooja, Sanchorawala, Vaishali, Brauneis, Dina, Sloan, J. Mark, Siddiqi, Omar K., Quillen, Karen, Sarosiek, Shayna
Published in Bone marrow transplantation (Basingstoke) (01.08.2019)
Published in Bone marrow transplantation (Basingstoke) (01.08.2019)
Get full text
Journal Article
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients
Gill, Sarvarinder K., Unawane, Rashmi, Wang, Shuqi, Ahn, Jaeil, Aleman, Adolfo, Siegel, David S., Vesole, David H., Parmar, Harsh, Phull, Pooja, Biran, Noa
Published in Blood cancer journal (New York) (23.09.2022)
Published in Blood cancer journal (New York) (23.09.2022)
Get full text
Journal Article
Sequential Administration of Selinexor and CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Gill, Sarvarinder Kaur, Biran, Noa, Phull, Pooja, Vesole, David H., Siegel, David S., Parmar, Harsh
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Single-Center Experience of Carfilzomib-Based Combinations for Patients with Lymphoplasmacytic Lymphoma
Parmar, Harsh, Biran, Noa, Phull, Pooja, Vesole, David H., Siegel, David S.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Real-World Comparison of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel CAR-T Therapy: A Single Center Experience for Relapsed/ Refractory Multiple Myeloma
Gill, Sarvarinder Kaur, Biran, Noa, Phull, Pooja, Vesole, David H., Siegel, David S., Parmar, Harsh
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
Bangolo, Ayrton, Oza, Samir, Slotky, Ronit, Chappell, Aimee, Siegel, David, Parmar, Harsh, Biran, Noa, Vesole, David H., Phull, Pooja
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Comparison of Fludarabine/Cyclophosphamide Vs Bendamustine As Lymphodepleting Regimen for CAR-T: A Safety and Efficacy Analysis in Patients with Relapsed/ Refractory Multiple Myeloma
Gill, Sarvarinder Kaur, Biran, Noa, Phull, Pooja, Kaur, Sukhdeep, Suh, Hyung C, Cho, Christina, Donato, Michele L., Rowley, Scott D, Vesole, David H., Siegel, David S., Parmar, Harsh
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Effect of Daratumumab on Stem Cell Mobilization and Engraftment Kinetics Post Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
Oza, Samir, Slotky, Ronit, Vissa, Pranay, Phull, Pooja, Kaur, Sukhdeep, Suh, Hyung C., Donato, Michele L., Rowley, Scott D., Biran, Noa, Vesole, David H., Siegel, David, Parmar, Harsh
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
P-224 Single-center experience of selinexor-based combination therapies for relapsed multiple myeloma
Ahmed, Noreen, Wan, Shucen, Biran, Noa, Phull, Pooja, Ip, Andrew, Doucette, Kimberley, Vesole, David, Siegel, David, Parmar, Harsh
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study
Zolotov, Eli, Kabat, Maciej, Parmar, Harsh, Anand, Palka, Zenreich, Joshua, Aleman, Adolfo, Phull, Pooja, Doucette, Kimberly, Vesole, David H, Siegel, David S, Biran, Noa
Published in Leukemia & lymphoma (31.07.2024)
Published in Leukemia & lymphoma (31.07.2024)
Get more information
Journal Article
A Phase 2b Study of Selinexor in Combination with Carfilzomib, Daratumumab, or Pomalidomide in Patients with Multiple Myeloma Relapsing on Current Therapy
Biran, Noa, Vesole, David H., Parmar, Harsh, Phull, Pooja, Doucette, Kimberly, Feinman, Rena, Zenreich, Joshua, Anand, Palka, Ivanovski, Kristin, Pace, Monique, Biamonte, Lisa, Campanaro, Martha, McClendon, Trina, Limbad, Chandani, BaboolallAracena, Samanta, Aleman, Adolfo, Unawane, Rashmi, Pendergrass, Elizabeth, Layton, Marie, Breeze, Genevieve, Chappell, Aimee, Della Pia, Alexandra, Kumka, Susan, Siegel, David S.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 1/2 Study of Carfilzomib, Iberdomide and Dexamethasone (KID) in Patients with Newly Diagnosed Transplant-Eligible Multiple Myeloma
Biran, Noa, Vesole, David H., Parmar, Harsh, Phull, Pooja, Doucette, Kimberly, Feinman, Rena, Zenreich, Joshua, Anand, Palka, Ivanovski, Kristin, Pace, Monique, Biamonte, Lisa, Campanaro, Martha, McClendon, Trina, Limbad, Chandani, BaboolallAracena, Samanta, Aleman, Adolfo, Unawane, Rashmi, Pendergrass, Elizabeth, Layton, Marie, Breeze, Genevieve, Chappell, Aimee, Della Pia, Alexandra, Kumka, Susan, Siegel, David S.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
Bangolo, Ayrton, Oza, Samir, Slotky, Ronit, Chappell, Aimee, Siegel, David, Parmar, Harsh, Biran, Noa, Vesole, David H, Phull, Pooja
Published in Current stem cell research & therapy (03.04.2024)
Published in Current stem cell research & therapy (03.04.2024)
Get more information
Journal Article
A phase I/II study of carfilzomib, iberdomide (CC-220), and dexamethasone (KID) in patients with newly diagnosed transplant-eligible multiple myeloma
Biran, Noa, Vesole, David H., Parmar, Harsh V., Phull, Pooja, Doucette, Kimberley, Feinman, Rena, Zenreich, Joshua, Anand, Palka, Ivanovski, Kristin, Pace, Monique, Breeze, Genevieve, Amer, Rania, Biamonte, Lisa, Aleman, Adolfo, Unawane, Rashmi, Pendergrass, Elizabeth, Della Pia, Alexandra, Kumka, Susan, Siegel, David Samuel DiCapua
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase IIb study of selinexor in combination with carfilzomib, daratumumab, or pomalidomide in patients with multiple myeloma relapsing on current therapy
Biran, Noa, Vesole, David H., Parmar, Harsh V., Phull, Pooja, Doucette, Kimberley, Feinman, Rena, Zenreich, Joshua, Anand, Palka, Ivanovski, Kristin, Pace, Monique, Breeze, Genevieve, Amer, Rania, Biamonte, Lisa, Aleman, Adolfo, Unawane, Rashmi, Pendergrass, Elizabeth, Della Pia, Alexandra, Kumka, Susan, Siegel, David Samuel DiCapua
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
The Clinical Characteristics and Epidemiology of Extramedullary Multiple Myeloma over the Past Two Decades
Bangolo, Ayrton, Fwelo, Pierre, Trivedi, Chinmay, Hashem, Jennifer, Jandir, Parul, Klaichart, Katamon, Abdelrahim, Rua, Perera, Ayodya R, Singh, Manbir, Gurumoorthy, Rohini B, Tiwari, Apurva, Konakanchi, Sudha S, Orhun, Nagihan, Polavarapu, Adithya, Sharma, Ritika, Sarkar, Ankit, Gupta, Anupama, Treisma, Bob-Hallen E., Thiri Soe, Thin, Penchala, Ashwin, Penmetsa, Sheetal, Bathi, Srikar, Muppalla, Padmavathi, Siegel, David, Biran, Noa, Parmar, Harsh, Vesole, David H., Weissman, Simcha, Phull, Pooja
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
Parikh, Ravi B, Takvorian, Samuel U, Vader, Daniel, Paul Wileyto, E, Clark, Amy S, Lee, Daniel J, Goyal, Gaurav, Rocque, Gabrielle B, Dotan, Efrat, Geynisman, Daniel M, Phull, Pooja, Spiess, Philippe E, Kim, Roger Y, Davidoff, Amy J, Gross, Cary P, Neparidze, Natalia, Miksad, Rebecca A, Calip, Gregory S, Hearn, Caleb M, Ferrell, Will, Shulman, Lawrence N, Mamtani, Ronac, Hubbard, Rebecca A
Published in JNCI : Journal of the National Cancer Institute (11.04.2022)
Published in JNCI : Journal of the National Cancer Institute (11.04.2022)
Get full text
Journal Article